RECRUITING

Fidgeting and Attentional and Emotional Regulation in ADHD

Conditions

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This project will study how fidgeting relates to cognitive and emotional functioning in adults with attention-deficit/hyperactivity disorder (ADHD). It will determine, in a laboratory setting, whether movement and access to a "fidget device" providing sensory and motor stimulation can improve cognitive and emotional regulation (including on physiological measures) in adult ADHD. The investigators will also acquire pilot data for machine learning analyses to be used in future, large scale studies to identify gestures and touch characteristics associated with improved cognitive and emotional regulation to see if the data can predict and subsequently develop recommendations to improve performance and emotional control in natural settings (e.g., home, office, college classroom) for adult ADHD.

Official Title

Can Fidgeting Lead to Enhanced Attention and Emotional Regulation in ADHD?

Quick Facts

Study Start:2022-03-21
Study Completion:2025-07-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04526600

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 30 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. * ADHD
  2. * History of fidgeting
  1. * Currently taking psychoactive medication, with the exception of stimulant medication for ADHD or medication that can affect heart rate;
  2. * Presence of significant depression or psychotic disorders, autism, visual or hearing impairment or any other disorder that may interfere with task performance; and IQ below 85

Contacts and Locations

Study Contact

Jared Borden
CONTACT
916-703-0294
jborden@ucdavis.edu

Principal Investigator

Julie Schweitzer, Ph.D.
PRINCIPAL_INVESTIGATOR
UC Davis MIND Institute

Study Locations (Sites)

UC Davis MIND Institute
Sacramento, California, 95817
United States

Collaborators and Investigators

Sponsor: University of California, Davis

  • Julie Schweitzer, Ph.D., PRINCIPAL_INVESTIGATOR, UC Davis MIND Institute

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2022-03-21
Study Completion Date2025-07-01

Study Record Updates

Study Start Date2022-03-21
Study Completion Date2025-07-01

Terms related to this study

Additional Relevant MeSH Terms

  • ADHD